Description: Evrysdi® (risdiplam) is a Spinal Muscular Atrophy (SMA) treatment that can be administered at home and is approved for use in adults, children, and infants. Please see Important Safety Information including the Full Prescribing Information for more details.
* Number of people taking Evrysdi as of October 2022. † Evrysdi clinical trials did not include people aged 65 and older to determine whether they respond differently from those who are younger.
Evrysdi is a prescription medicine used to treat spinal muscular atrophy (SMA) in children and adults.
These are not all of the possible side effects of Evrysdi. For more information on the risk and benefits profile of Evrysdi, ask your healthcare provider or pharmacist.